ISOPROTERENOL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Isoproterenol Hydrochloride patents expire, and when can generic versions of Isoproterenol Hydrochloride launch?
Isoproterenol Hydrochloride is a drug marketed by 3M, Alpharma Us Pharms, Abraxis Pharm, Am Regent, Amneal, Amphastar Pharms Inc, Amring Pharms, Avet Lifesciences, Baxter Hlthcare, Cipla, Eugia Pharma, Hikma, Hospira, Intl Medication, Micro Labs, Mylan Labs Ltd, Nexus, Penn Life, Zydus Pharms, Armour Pharm, DEY, and Parke Davis. and is included in twenty-six NDAs.
The generic ingredient in ISOPROTERENOL HYDROCHLORIDE is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isoproterenol Hydrochloride
A generic version of ISOPROTERENOL HYDROCHLORIDE was approved as isoproterenol hydrochloride by NEXUS on August 2nd, 2017.
Summary for ISOPROTERENOL HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 22 |
| NDAs: | 26 |
| Finished Product Suppliers / Packagers: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 118 |
| Clinical Trials: | 24 |
| Patent Applications: | 963 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in ISOPROTERENOL HYDROCHLORIDE? | ISOPROTERENOL HYDROCHLORIDE excipients list |
| DailyMed Link: | ISOPROTERENOL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for ISOPROTERENOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University | Phase 4 |
| Ningbo No. 1 Hospital | Phase 4 |
| Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 |
Pharmacology for ISOPROTERENOL HYDROCHLORIDE
| Drug Class | beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic beta-Agonists |
